Exact Sciences (EXAS) Tops Q1 EPS by 1c, Company Pleased with Launch Trajectory of Cologuard

Go back to Exact Sciences (EXAS) Tops Q1 EPS by 1c, Company Pleased with Launch Trajectory of Cologuard

Lake Street Capital Markets Downgrades Exact Sciences (EXAS) to Hold

May 5, 2015 9:22 AM EDT

Lake Street Capital Markets downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Hold with a price target of $24.00 (from $28.00). The change follows Q1 results, which were described as slightly better than expected. Analyst Bruce D. Jackson said Cologuard unit ramp and commercial pricing... More